Financhill
Back

Akebia Therapeutics Vs. Aquestive Therapeutics Industry Stock Comparison

Sell
42

AKBA
Akebia Therapeutics

Last Price:
1.16
Seasonality Move:
-7.41%
Buy
51

AQST
Aquestive Therapeutics

Last Price:
3.10
Seasonality Move:
9.86%
Sell
42
Akebia Therapeutics (AKBA) is a Sell

Is Akebia Therapeutics a Buy, Sell or Hold?

  • The current Akebia Therapeutics [AKBA] share price is $1.15. The Score for AKBA is 42, which is 16% below its historic median score of 50, and infers higher risk than normal.
  • AKBA is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
51
Aquestive Therapeutics (AQST) is a Buy

Is Aquestive Therapeutics a Buy, Sell or Hold?

  • The current Aquestive Therapeutics [AQST] share price is $3.11. The Score for AQST is 51, which is 2% above its historic median score of 50, and infers lower risk than normal.
  • AQST is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

AKBA Stock Price Chart

What is Akebia Therapeutics's stock price today?

  • The Akebia Therapeutics share price today is $1.15
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and AKBA is experiencing slight selling pressure.

AQST Stock Price Chart

What is Aquestive Therapeutics's stock price today?

  • The Aquestive Therapeutics share price today is $3.11
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and AQST is experiencing selling pressure, which indicates risk of future bearish movement.

AKBA Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.08 Sell
Relative Strength Index (14 RSI): 36.32 Sell
Chaikin Money Flow: 0 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (1.23 - 1.41) Sell
Bollinger Bands (100): (1.29 - 1.73) Sell

AQST Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.23 Sell
Relative Strength Index (14 RSI): 39.25 Sell
Chaikin Money Flow: -758826 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (3.2 - 4.04) Sell
Bollinger Bands (100): (2.46 - 4.4) Sell

AKBA Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 1.24 Sell
20-day SMA: 1.3 Sell
50-day SMA: 1.5 Sell
200-day SMA: 1.31 Sell
8-day EMA: 1.22 Sell
20-day EMA: 1.31 Sell
50-day EMA: 1.41 Sell
200-day EMA: 1.32 Sell

AQST Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 3.19 Sell
20-day SMA: 3.51 Sell
50-day SMA: 4.08 Sell
200-day SMA: 2.58 Buy
8-day EMA: 3.24 Sell
20-day EMA: 3.46 Sell
50-day EMA: 3.65 Sell
200-day EMA: 2.87 Buy

Akebia Therapeutics Earnings Growth & AKBA Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.00 per share, an increase next quarter of $0.10 per share, an increase this year of $0.05 per share, and an increase next year of $0.05 per share.

Aquestive Therapeutics Earnings Growth & AQST Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, an increase next quarter of $0.00 per share, a decrease this year of $0.19 per share, and an increase next year of $0.03 per share.

Akebia Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Aquestive Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):